
Biomet Inc. bought out Braintree, Mass.-based Cytosol Laboratories Inc.
The Warsaw, Ind.-based firm manufactures reconstructive products for musculoskeletal applications in both surgical and non-surgical treatments. The company plans to incorporate Cytosol’s anticoagulants and other blood component processing products into its product lines.
Biomet Biologics president Stuart Kleopfer said the acquisition solidifies the supply of a component used by the company’s platelet separation and concentration systems.